Bora Gürel

7.0k total citations
57 papers, 2.9k citations indexed

About

Bora Gürel is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Bora Gürel has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 21 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Bora Gürel's work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bora Gürel is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bora Gürel collaborates with scholars based in United States, United Kingdom and Türkiye. Bora Gürel's co-authors include Angelo M. De Marzo, Jessica Hicks, William B. Isaacs, Srinivasan Yegnasubramanian, Siobhan Sutcliffe, William G. Nelson, Michael C. Haffner, David Esopi, Jianfeng Xu and George J. Netto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Bora Gürel

53 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bora Gürel United States 24 1.5k 1.4k 722 661 287 57 2.9k
Robert A. Sikes United States 31 1.3k 0.8× 1.6k 1.1× 608 0.8× 956 1.4× 173 0.6× 71 3.3k
Iris E. Eder Austria 29 1.5k 1.0× 1.4k 0.9× 728 1.0× 623 0.9× 237 0.8× 72 3.0k
Jacek Pinski United States 31 1.1k 0.7× 1.1k 0.8× 415 0.6× 727 1.1× 262 0.9× 114 2.9k
Makoto Sumitomo Japan 28 794 0.5× 1.3k 0.9× 667 0.9× 849 1.3× 348 1.2× 133 2.5k
Guido Bellezza Italy 28 942 0.6× 830 0.6× 581 0.8× 1.0k 1.6× 247 0.9× 124 2.4k
Stéphane Terry France 33 1.4k 0.9× 1.6k 1.1× 1.1k 1.5× 1.1k 1.7× 177 0.6× 68 3.6k
Xianxian Zheng United States 20 958 0.6× 1.7k 1.2× 524 0.7× 1.1k 1.7× 143 0.5× 30 3.4k
Junichi Inokuchi Japan 28 1.0k 0.7× 1.1k 0.8× 533 0.7× 478 0.7× 401 1.4× 161 2.4k
Gerald W. Verhaegh Netherlands 31 1.8k 1.2× 2.7k 1.9× 1.9k 2.7× 822 1.2× 552 1.9× 97 4.6k
Jonathan M. Kurie United States 31 1.2k 0.8× 2.2k 1.5× 1.2k 1.6× 1.6k 2.4× 187 0.7× 73 4.0k

Countries citing papers authored by Bora Gürel

Since Specialization
Citations

This map shows the geographic impact of Bora Gürel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bora Gürel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bora Gürel more than expected).

Fields of papers citing papers by Bora Gürel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bora Gürel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bora Gürel. The network helps show where Bora Gürel may publish in the future.

Co-authorship network of co-authors of Bora Gürel

This figure shows the co-authorship network connecting the top 25 collaborators of Bora Gürel. A scholar is included among the top collaborators of Bora Gürel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bora Gürel. Bora Gürel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eltan, Sevgi Bilgiç, Bora Gürel, Safa Barış, et al.. (2025). The Discrepancy Between Perceived and Proven Drug Hypersensitivity in a Well‐Defined Cohort of Patients With Inborn Errors of Immunity. Allergy. 80(11). 3140–3150. 1 indexed citations
2.
Fisher, Matthew, Mateus Crespo, Bora Gürel, et al.. (2024). Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer. 12(7). e009368–e009368. 7 indexed citations
4.
Bono, Johann S. de, Simon Lord, Christina Yap, et al.. (2023). 687P A CRUK phase I/IIA, first in human dose-escalation and expansion trial of HMBD-001 (an anti-HER3 antibody) in patients with advanced HER3 positive solid tumours. Annals of Oncology. 34. S479–S480. 1 indexed citations
5.
Neeb, Antje, Ines Figueiredo, Bora Gürel, et al.. (2023). Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. Laboratory Investigation. 103(11). 100245–100245.
6.
Sheehan, Beshara, Antje Neeb, Lorenzo Buroni, et al.. (2022). Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer. Clinical Cancer Research. 28(14). 3104–3115. 22 indexed citations
9.
Trock, Bruce J., Helen Fedor, Bora Gürel, et al.. (2016). PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance. Modern Pathology. 29(7). 764–771. 46 indexed citations
10.
Nash, Sarah H., Jeannette M. Schenk, Alan R. Kristal, et al.. (2015). Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prevention Research. 8(7). 590–596. 8 indexed citations
11.
Uğurlucan, Murat, Müjdat Uysal, Ömer Ali Sayın, et al.. (2014). Effects of Ginkgo biloba Extract on Spinal Cord Ischemia–Reperfusion Injury in Rats. Annals of Vascular Surgery. 28(5). 1296–1305. 8 indexed citations
12.
Gümüşkaya, Berrak, Bora Gürel, Helen Fedor, et al.. (2013). Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion. Prostate Cancer and Prostatic Diseases. 16(2). 209–215. 58 indexed citations
13.
Iwata, Tsuyoshi, Bora Gürel, Denise Schultz, et al.. (2012). Global Levels of H3K27me3 Track with Differentiation in Vivo and Are Deregulated by MYC in Prostate Cancer. American Journal Of Pathology. 181(2). 560–569. 44 indexed citations
14.
Lotan, Tamara L., Bora Gürel, Siobhan Sutcliffe, et al.. (2011). PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients. Clinical Cancer Research. 17(20). 6563–6573. 262 indexed citations
15.
Gürel, Bora, Tehmina Z. Ali, Elizabeth A. Montgomery, et al.. (2010). NKX3.1 as a Marker of Prostatic Origin in Metastatic Tumors. The American Journal of Surgical Pathology. 34(8). 1097–1105. 179 indexed citations
16.
Gürel, Bora, et al.. (2009). Langerhans' cell histiocytosis mimicking metastatic carcinoma of the lung. Respirology. 14(3). 456–458. 2 indexed citations
17.
Yegnasubramanian, Srinivasan, Michael C. Haffner, Yonggang Zhang, et al.. (2008). DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity. Cancer Research. 68(21). 8954–8967. 214 indexed citations
18.
Gürel, Bora, Tsuyoshi Iwata, Cheryl M. Koh, et al.. (2008). Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets. Advances in Anatomic Pathology. 15(6). 319–331. 42 indexed citations
19.
Gürer-Orhan, Hande, et al.. (2008). Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats. Experimental and Toxicologic Pathology. 61(1). 23–32. 77 indexed citations
20.
Harmancı, Özgür, İbrahi̇m Koral Önal, Osman Ersoy, et al.. (2007). Postinfantile Giant Cell Hepatitis Due to Hepatitis E Virus Along with the Presence of Autoantibodies. Digestive Diseases and Sciences. 52(12). 3521–3523. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026